CI Investments Inc
VRTX icon

CI Investments Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

CI Investments Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.25M Sell
14,000
-35,891
-72% -$16.7M 0.03% 270
2025
Q4 		$22.6M Buy
49,891
+38,900
+354% +$16.8M 0.1% 166
2025
Q3 		$4.3M Sell
10,991
-2,137
-16% -$893K 0.02% 307
2025
Q2 		$5.84M Sell
13,128
-17,886
-58% -$8.24M 0.02% 288
2025
Q1 		$15M Sell
31,014
-4,854
-14% -$2.26M 0.06% 189
2024
Q4 		$14.4M Sell
35,868
-18,058
-33% -$8.37M 0.05% 201
2024
Q3 		$25.1M Buy
53,926
+40,498
+302% +$19.5M 0.1% 156
2024
Q2 		$6.29M Buy
13,428
+3,640
+37% +$1.58M 0.02% 258
2024
Q1 		$4.09M Buy
9,788
+3,025
+45% +$1.28M 0.02% 302
2023
Q4 		$2.75M Sell
6,763
-950
-12% -$351K 0.01% 307
2023
Q3 		$2.68M Sell
7,713
-512
-6% -$179K 0.02% 304
2023
Q2 		$2.9M Sell
8,225
-1,226
-13% -$413K 0.01% 306
2023
Q1 		$2.98M Buy
9,451
+1,737
+23% +$521K 0.02% 301
2022
Q4 		$2.23M Buy
7,714
+350
+5% +$107K 0.01% 322
2022
Q3 		$2.13M Buy
7,364
+1,701
+30% +$489K 0.01% 334
2022
Q2 		$1.6M Sell
5,663
-777
-12% -$208K 0.01% 353
2022
Q1 		$1.68M Buy
6,440
+551
+9% +$131K 0.01% 392
2021
Q4 		$1.29M Buy
5,889
+230
+4% +$44.7K ﹤0.01% 422
2021
Q3 		$1.03M Buy
5,659
+1,492
+36% +$291K ﹤0.01% 457
2021
Q2 		$840K Sell
4,167
-1,728
-29% -$361K ﹤0.01% 497
2021
Q1 		$1.27M Buy
5,895
+1,697
+40% +$373K 0.01% 374
2020
Q4 		$992K Sell
4,198
-91
-2% -$20.9K ﹤0.01% 389
2020
Q3 		$1.17M Sell
4,289
-227
-5% -$62.6K 0.01% 348
2020
Q2 		$1.31M Buy
4,516
+679
+18% +$184K 0.01% 338
2020
Q1 		$913K Buy
3,837
+2,720
+244% +$624K 0.01% 358
2019
Q4 		$245K Buy
1,117
+1,000
+855% +$202K ﹤0.01% 546
2019
Q3 		$20K Buy
+117
New +$20.7K ﹤0.01% 576
2019
Q1 		– Sell
-700
Closed -$116K – 371
2018
Q4 		$116K Buy
+700
New +$121K ﹤0.01% 306

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CI Investments Inc's VRTX Position: Q1 2026 in Review

CI Investments Inc reduced its Vertex Pharmaceuticals (VRTX) stake by 72% in Q1 2026, selling an estimated $16.7M and leaving 14,000 shares worth $6.25M. The position accounts for 0.03% of the portfolio, ranked #270.

CI Investments Inc first reported a position in VRTX in Q4 2018 and has held it in 28 quarters since. The position peaked at $25.1M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • CI Investments Inc held 14,000 shares of Vertex Pharmaceuticals worth $6.25M as of Q1 2026.
  • CI Investments Inc sold 35,891 Vertex Pharmaceuticals shares in Q1 2026, an estimated $16.7M.
  • Vertex Pharmaceuticals made up 0.03% of CI Investments Inc's portfolio in Q1 2026, its #270 holding.
  • CI Investments Inc first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 28 quarters since.
  • CI Investments Inc's Vertex Pharmaceuticals position peaked at $25.1M in Q3 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.